Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-08-035474
Filing Date
2008-06-17
Accepted
2008-06-16 20:01:09
Documents
5

Document Format Files

Seq Description Document Type Size
1 v117455_s3.htm S-3 491240
2 v117455_ex4-3.htm EX-4.3 522660
3 v117455_ex5-1.htm EX-5.1 28500
4 v117455_ex23-1.htm EX-23.1 5069
5 v117455_ex23-2.htm EX-23.2 4957
  Complete submission text file 0001144204-08-035474.txt   1053849
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-151696 | Film No.: 08901721
SIC: 2836 Biological Products, (No Diagnostic Substances)